Document Detail


Quantitative determinants of the outcome of asymptomatic mitral regurgitation.
MedLine Citation:
PMID:  15745978     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The clinical outcome of asymptomatic mitral regurgitation is poorly defined, and the treatment is uncertain. We studied the effect on the outcome of quantifying mitral regurgitation according to recent guidelines. METHODS: We prospectively enrolled 456 patients (mean [+/-SD] age, 63+/-14 years; 63 percent men; ejection fraction, 70+/-8 percent) with asymptomatic organic mitral regurgitation, quantified according to current recommendations (regurgitant volume, 66+/-40 ml per beat; effective regurgitant orifice, 40+/-27 mm2). RESULTS: The estimated five-year rates (+/-SE) of death from any cause, death from cardiac causes, and cardiac events (death from cardiac causes, heart failure, or new atrial fibrillation) with medical management were 22+/-3 percent, 14+/-3 percent, and 33+/-3 percent, respectively. Independent determinants of survival were increasing age, the presence of diabetes, and increasing effective regurgitant orifice (adjusted risk ratio per 10-mm2 increment, 1.18; 95 percent confidence interval, 1.06 to 1.30; P<0.01), the predictive power of which superseded all other qualitative and quantitative measures of regurgitation. Patients with an effective regurgitant orifice of at least 40 mm2 had a five-year survival rate that was lower than expected on the basis of U.S. Census data (58+/-9 percent vs. 78 percent, P=0.03). As compared with patients with a regurgitant orifice of less than 20 mm2, those with an orifice of at least 40 mm2 had an increased risk of death from any cause (adjusted risk ratio, 2.90; 95 percent confidence interval, 1.33 to 6.32; P<0.01), death from cardiac causes (adjusted risk ratio, 5.21; 95 percent confidence interval, 1.98 to 14.40; P<0.01), and cardiac events (adjusted risk ratio, 5.66; 95 percent confidence interval, 3.07 to 10.56; P<0.01). Cardiac surgery was ultimately performed in 232 patients and was independently associated with improved survival (adjusted risk ratio, 0.28; 95 percent confidence interval, 0.14 to 0.55; P<0.01). CONCLUSIONS: Quantitative grading of mitral regurgitation is a powerful predictor of the clinical outcome of asymptomatic mitral regurgitation. Patients with an effective regurgitant orifice of at least 40 mm2 should promptly be considered for cardiac surgery.
Authors:
Maurice Enriquez-Sarano; Jean-François Avierinos; David Messika-Zeitoun; Delphine Detaint; Maryann Capps; Vuyisile Nkomo; Christopher Scott; Hartzell V Schaff; A Jamil Tajik
Related Documents :
12970218 - Efficacy of chordal cutting to relieve chronic persistent ischemic mitral regurgitation.
3315668 - Quantification of valvular regurgitation using radioisotopes.
19933288 - An ethical dilemma: severe ischaemic mitral regurgitation and acute coronary syndrome i...
14565708 - Current profile of acute rheumatic fever and valvulitis in southern india.
9316508 - First international new intravascular rigid-flex endovascular stent study (finess): cli...
15253738 - Myocardial scintigraphy using a fatty acid analogue detects coronary artery disease in ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.    
Journal Detail:
Title:  The New England journal of medicine     Volume:  352     ISSN:  1533-4406     ISO Abbreviation:  N. Engl. J. Med.     Publication Date:  2005 Mar 
Date Detail:
Created Date:  2005-03-04     Completed Date:  2005-03-08     Revised Date:  2007-11-15    
Medline Journal Info:
Nlm Unique ID:  0255562     Medline TA:  N Engl J Med     Country:  United States    
Other Details:
Languages:  eng     Pagination:  875-83     Citation Subset:  AIM; IM    
Copyright Information:
Copyright 2005 Massachusetts Medical Society.
Affiliation:
Division of Cardiovascular Diseases and Internal Medicine, Mayo Clinic, Rochester, Minn 55905, USA. sarano.maurice@mayo.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Analysis of Variance
Atrial Fibrillation / etiology
Echocardiography, Doppler
Female
Heart Failure / etiology
Hemodynamics
Humans
Male
Middle Aged
Mitral Valve / ultrasonography
Mitral Valve Insufficiency / classification*,  complications*,  mortality,  surgery
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Prospective Studies
Severity of Illness Index
Survival Rate
Treatment Outcome
Ventricular Function
Grant Support
ID/Acronym/Agency:
HL 64928/HL/NHLBI NIH HHS
Comments/Corrections
Comment In:
N Engl J Med. 2005 May 26;352(21):2245-6; author reply 2245-6   [PMID:  15917393 ]
N Engl J Med. 2005 Mar 3;352(9):928-9   [PMID:  15745985 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  U.K. Controlled trial of intrapleural streptokinase for pleural infection.
Next Document:  Family-based association between Alzheimer's disease and variants in UBQLN1.